{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:52:08Z","timestamp":1791431528119,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ahj.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:33:44Z","timestamp":1292474024000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: Summary of the literature and implications for genetic testing"],"prefix":"10.1016","volume":"161","author":[{"given":"Andrew P.","family":"Landstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde A.","family":"Adekola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2010.08.001_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.08.001_bb0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.CIR.62.2.218","article-title":"Sudden death in young athletes","volume":"62","author":"Maron","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.08.001_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0735-1097(86)80283-2","article-title":"Causes of sudden death in competitive athletes","volume":"7","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2004.04.039","article-title":"Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.CIR.0000080896.52003.DF","article-title":"Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy","volume":"108","author":"Van Driest","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.08.001_bb0030","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.yjmcc.2007.04.006","article-title":"Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans","volume":"42","author":"Landstrom","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yjmcc.2007.06.009","article-title":"Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy","volume":"43","author":"Chiu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2008.05.003","article-title":"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C","volume":"45","author":"Landstrom","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0050","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1016\/S0021-9258(18)69309-3","article-title":"Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains","volume":"261","author":"Simmerman","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2010.08.001_bb0055","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0021-9258(17)36010-6","article-title":"The nature of the modulation of Ca2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum","volume":"261","author":"Inui","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2010.08.001_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2010.08.001_bb0065","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","article-title":"Identification of a gene responsible for familial Wolff-Parkinson-White syndrome","volume":"344","author":"Gollob","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.08.001_bb0070","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.08.001_bb0075","first-page":"784","article-title":"Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease","volume":"47","author":"Sakuraba","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ahj.2010.08.001_bb0080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2010.08.001_bb0085","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.08.001_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejheart.2006.04.007","article-title":"Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN \u221242 C>G mutation","volume":"9","author":"Medin","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2010.08.001_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(03)00526-6","article-title":"Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy","volume":"304","author":"Minamisawa","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ahj.2010.08.001_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2261-9-33","article-title":"No evidence for an association between the \u221236A>C phospholamban gene polymorphism and a worse prognosis in heart failure","volume":"9","author":"Santos","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2010.08.001_bb0105","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/humu.20692","article-title":"A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids","volume":"29","author":"Haghighi","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ahj.2010.08.001_bb0110","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ahj.2010.08.001_bb0115","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ahj.2010.08.001_bb0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2010.08.001_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","article-title":"Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy","volume":"111","author":"Hoign\u00e9","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0130","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.jacc.2007.09.022","article-title":"Detection of subclinical Fabry disease in patients presenting with hypertrophic cardiomyopathy","volume":"50","author":"Ackerman","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.08.001_bb0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10528-005-9121-8","article-title":"Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a northern Greek population","volume":"43","author":"Kalemi","year":"2005","journal-title":"Biochem Genet"},{"key":"10.1016\/j.ahj.2010.08.001_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/humu.20749","article-title":"A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy","volume":"29","author":"Fokstuen","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ahj.2010.08.001_bb0145","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.109.863076","article-title":"Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants","volume":"120","author":"Kapa","year":"2009","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310006757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310006757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:44:06Z","timestamp":1757569446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870310006757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0002870310006757"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2010.08.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: Summary of the literature and implications for genetic testing","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2010.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}